Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 1-10 of 55

Page
per page
  1. Alisol B 23-acetate
    N1550 Alisol B 23-acetate
    Target: Pregnane X Receptors
      ≥51.5 mg/mL
  2. 7-Ethyl-10-hydroxycamptothecin
    N2133 7-Ethyl-10-hydroxycamptothecin
    Target: Topoisomerases
    Summary: TOPO I inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
  3. FT-207 (NSC 148958)
    B1474 FT-207 (NSC 148958)
    Summary: DNA/RNA synthesis inhibitor
      ≥100 mg/mL
  4. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
  5. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL
  6. Pemetrexed
    A4390 Pemetrexed
     1 Citation
    Target: Thymidylate Synthase|DHFR|GARFT
    Summary: TS, DHFR,GARFT and AICARFT inhibitor
      insoluble in EtOH; ≥15.68 mg/mL
  7. Ellipticine
    B7382 Ellipticine
    Target: Topoisomerases
    Summary: DNA topoisomerase II inhibitor
      ≥24.6 mg/mL
  8. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  9. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  10. PLX-4720
    A3016 PLX-4720
     1 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥20.69 mg/mL

Items 1-10 of 55

Page
per page